0% found this document useful (0 votes)
9 views5 pages

Toxicological Study of An Exhumed Body Using Alternative Matrices For The Detection of Psychoactive Drugs

Uploaded by

alinahassan109
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
9 views5 pages

Toxicological Study of An Exhumed Body Using Alternative Matrices For The Detection of Psychoactive Drugs

Uploaded by

alinahassan109
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 5

Rom J Leg Med [28] 398-402 [2020]

DOI: 10.4323/rjlm.2020.398
© 2020 Romanian Society of Legal Medicine FORENSIC TOXICOLOGY

TOXICOLOGICAL STUDY OF AN EXHUMED BODY USING ALTERNATIVE MATRICES FOR


THE DETECTION OF PSYCHOACTIVE DRUGS

Cristina Pérez-Martínez1,*, Lucía Fernández-López1, Gemma Prieto-Bonete1, Aurelio Luna1

University of Murcia, School of Medicine, Regional Campus of International Excellence “Campus Mare Nostrum”,
Department of Legal and Forensic Medicine, Murcia, Spain

Abstract: In forensic toxicology, systematic toxicological analyses (STA) and interpretation of results are difficult
when routine matrices such as blood (typically from a central and peripheral source), urine, bile, vitreous humor, stomach or
gastric contents are not available. Furthermore, in instances of limited remains, only muscle, hair, or a skeleton may be available
for toxicological examination to unambiguously identify as many toxicologically relevant compounds as possible to assist in
determining the cause of death. This article describes a case of the exhumed corpse of a 53-year-old male known to have
been addicted to several types of drugs. The STA was carried out on alternative biological matrices, including brain, kidney
and bone marrow, using gas chromatography–mass spectrometry (GC-MS) and high-performance liquid chromatography–
mass spectrometry (HPLC-MS) and subsequently the identified substances were quantified by GC-MS and ultra-performance
liquid chromatography–tandem mass spectrometry (UPLC-MS/MS). The mixture found included multiple agents such as
barbiturates, benzodiazepines (BZD) and anaesthetic agent. We demonstrate the possibility of detection of several drugs in an
exhumed body 2 years after interment. Despite the problematic of interpreting the quantitative toxicological results, the data
could provide complementary information about aetiology of death.

Keywords: forensic toxicology, systematic toxicological analyses, exhumed corpse, alternative biological matrices,
gas chromatography–mass spectrometry, high performance liquid chromatography–mass spectrometry, ultra-performance
liquid chromatography–tandem mass spectrometry, drugs.

INTRODUCTION or corpses buried and later, and after a while, exhumed


[8], due to the uncertainty of finding evidences after a
Forensic toxicology is aiming to detect given post-mortem interval (PMI) [9].
possible xenobiotics, drugs and other potentially toxic Peripheral and cardiac blood, urine, vitreous
compounds in biological autopsy samples, quantify humour, bile, stomach or gastric contents are the
the concentrations of relevant and main compounds typical biological samples collected at autopsy [10-13].
found in samples, and contribute to the investigation However, in cases where routine specimens cannot
of the manner of death [1, 2]. In order to contribute to be analysed due to putrefaction or skeletonization
the understanding and assessment of these test results [12] or in cases when forensic autopsy cannot collect
in a medical-legal context [3], the use of appropriate adequate blood specimens [14], alternative matrices
analytical methods, tools, the technical knowledge of such as brain, kidney, liver, bone marrow and bone are
forensic toxicologists, etc. are necessary [4, 5]. In today’s useful for diagnostic purposes [3, 13]. But care must
society, medical and recreational drugs represent most be taken, because high drug concentrations in blood
of the compounds that cause fatal poisonings [1]. may increase further during the post-mortem period,
The interpretation of the results of a providing erroneous results: in such cases, the use of
toxicological analysis in post-mortem cases alternative specimens (such as brain, kidney, marrow
is complicated [6, 7], especially in the case of bone, bone, etc.) will help improve forensic research
decomposing, poorly preserved, skeletonized bodies and hopefully lead to a more complete understanding

*Correspondence to: Cristina Pérez-Martínez, PhD, University of Murcia, School of Medicine, Regional Campus of International Excellence
“Campus Mare Nostrum”, Department of Legal and Forensic Medicine, E-30100, Murcia, Spain, E-mail: cristina.perez.mtnz@gmail.com
398
Toxicological study of an exhumed body using alternative matrices for the detection of psychoactive drugs

of any drug-related event [3]. 009) were obtained from Cerilliant (Round Rock, TX).
Besides variations in the type of sample, it The analytical and chromatographic solvents used were
has been found that the concentrations of drugs in acquired from Sigma Aldrich.
tissues, organs or body fluids can vary significantly
between death and the collection of the specimen Standard and post-mortem samples
[4]. Consequently, several factors must be considered preparation
such as the drug distribution and transformation Regression lines were assessed based on peak
in the perimortem and post-mortem states [15-23], areas ratios of each of the 5 compounds to that of the
the degradation of drugs, accidental or endogenous standards. The method showed linearity, expressed by
production and contamination, which can depend regression coefficient (R2) of above 0.975 in all cases.
on the intake routes and the chemical properties of The LOQ was found to be between 0.005 and 0.01
individual drugs and poisons [24-32]. All this makes it µg/mL depending on the analyte, and the LOD was
difficult to interpret post-mortem levels of drugs. between 0.0008 and 0.05 µg/mL.
In any case, in addition to taking into account Duplicate biological post-mortem samples
the type of sample, the conditions of the sample and were homogenized using an IKA® ULTRA-TURRAX®
the variations that may occur in the concentrations of disperser (Z404519, Sigma Aldrich). The homogenates
the drugs, other factors must be considered such as were subjected to a drugs extraction procedure. The
the scope of the analyses, the suitability of the sample procedure described by Yawney et al. [35] was carried
for the experiments, the stability or otherwise of the out in brain, kidney and liver post-mortem samples;
substances detected and other factors that influence while the protocol described by McIntyre et al. [36]
the variation of the concentrations in the samples [6, was followed in case of the bone marrow samples. The
11, 33-34]. Therefore, despite obtaining positive results extracts obtained from the processing of the samples
in the detection and quantifying drugs in biological were evaporated in nitrogen stream and reconstituted in
samples obtained from an autopsy, it is complicated 60 µl of mobile phase. Control and calibration standards
and sometimes not possible to interpret the results and were prepared by spiking methanol with standards at
extrapolate them to the antemortem state of the subject. concentrations ranging from 0.005 µg/g to 5 µg/g.
This article reports the use of alternative matrices
in post-mortem toxicological analysis in a case of Toxicological analysis
suspected multi-drug abuse death of a patient with The screening of illicit and therapeutic drugs
possible addiction habits. was performed by GC-MS and HPLC-MS after liquid-
liquid extraction (LLE) and the addition of 25 µl of IS.
CASE REPORT The determination of concentrations of compounds
such as propofol and pentobarbital was carried out by
A 53-year-old male was exhumed 2 years after GC–MS and UPLC-MS/MS were used for midazolam.
death following circumstantial proof and evidence The toxins were confirmed by comparing the retention
pointing to possible intentional intoxication. Despite times and mass spectra characteristics of the peaks with
the long burial period, the body was well preserved, those of standards and were quantified by means of
although it was not possible to collect routine biological external calibration curves.
samples. Toxicological analyses were performed on
bone marrow (20.1 g), brain (125 g) and kidney (48 RESULTS
g) at the Legal and Forensic Medicine Department of
the University of Murcia (External Service for Forensic General toxicological screening for common
Science and Techniques (SECYTEF). Analysis of both drugs performed in the alternative matrices available
illicit and therapeutic drugs were called for. - bone marrow, brain and kidney - revealed the
presence of the anaesthetic propofol, the barbiturate
Materials, standards and chemicals pentobarbital and BZD midazolam. These drugs were
Based on the results obtained using GC-MS confirmed and quantified as shown in Table 1 and
and HPLC-MS, the drugs with the highest toxicological since the natural formation of this kind of compound
relevance and deuterium-labeled standards were can be ruled out, the observations clearly pointed to
applied for Midazolam (M-908), Diazepam-D5 (D- the antemortem intake of propofol, pentobarbital and
902), Propofol-D17 (P-077) and Pentobarbital-D5 (P- midazolam.

399
Pérez-Martínez C. et al.

Table 1. Summary of findings of toxicological analyses.

Biological material
Analyte Bone marrow ppm (µg/g) Brain ppm (µg/g) Kidney ppm (µg/g)
Pentobarbital 0.2398 n.d. 0.0445
Propofol n.d. n.d. 0.8123
Midazolam 0.0055 0.2190 0.1050
n.d.: Not detected.

Our results evidenced of the existence of drug deposits after death [46], PMI, sample type,
propofol at a concentration of 0.8123 µg/g in the kidney dissemination, redistribution in body cavities and
sample, which may be due to rapid redistribution and drug metabolism after death [47, 48]. In addition, it is
metabolism by conjugation in the liver to glucuronide necessary to add the characteristics of the medications
and sulfate inactive metabolites, which are excreted by themselves - including lipid solubility, plasma protein
the kidney with elimination half-life of 23 hours [37]. binding and molecular size, all of which influence the
The amount of pentobarbital found in the volume of distribution [40].
bone marrow sample was of 0.2398 μg/g and in kidney Bibliographic references found on toxicological
sample a concentration of 0.0445 μg/g. It was found in studies in non-conventional samples of exhumed
the kidney sample because is cleared by the kidneys [38] corpses are scarce. The matrices used in these works
and its chemical stability, which allows it to be stored in have been putrefied material (abdominal area, muscles,
the bone marrow. This also may reflect chronicity since etc.), skin, tissue, hair, nail, ulna and radius; the range
it was not found in other samples, but further studies are of the PMI is between 10 days and 4.5 years and the
needed to determine aspects such as the dose required compounds that had been detected are opiates, BZD,
and the frequency of use of the drug necessary for it to morphine and 6-acetylmorphine, and other types of
be deposited in the bone [39]. drugs [8, 42, 49-51].
Midazolam was detected in three matrices, The most recent toxicological investigations
finding the highest concentration in brain (0.2190 μg/g) carried out into accidental deaths, suicides, homicides
possibly due to its high lipophilicity at physiological and cases of drug-facilitated sexual assault involving
pH, which explains for midazolam’s rapid absorption the compounds identified in our case (propofol,
and crossing of the blood-brain barrier [40, 41] BZDs pentobarbital and midazolam) showed higher
and their metabolites are distributed throughout the concentrations in normal matrices such as femoral,
body and accumulate mainly in lipid-rich areas such as cardiac and peripheral blood, head and pubic hair,
adipose tissue and the central nervous system, where it urine and tissue samples of medico-legal autopsies [43,
exerts its action [42, 43]. On the other hand, we found 52-71] than our results.
this compound in lower concentrations in the kidney Interpretation of the toxicological results
(0.1050 μg/g) coinciding with other study which reports obtained in different biological matrices of an exhumed
that it finally goes to the excretory organs [44]. corpse 2 years after death is difficult because the
processes of decomposition and putrefaction introduce
DISCUSSION substantial changes in the biological material.8 In
addition to the changes in the matrices, we found
The tasks carried out by forensic sciences substantial changes in the structure and composition
such as the identification and analysis of remains, of the drugs and toxicological problems arise as a
especially when it comes to decomposed or incomplete consequence of the instability of the chemical in this
bodies, is a complicated job [45]. Among the tests type of situation [72-74]. Together with the absence of
to be performed, we find the toxicological studies, routine material (blood, urine or bile), this may lead
which must be interpreted with great caution because to misinterpretation [72]. Despite these caveats, data
the pharmacodynamic and kinetic properties of the from this study point to the relevance of toxicological
compounds according to the different matrices are not analyses of alternative matrices to complement forensic
clearly known. On the other hand, the concentrations investigation.
found in biological samples will also depend on several In conclusion, the detected substances,
factors, which will cause them to be modified, such as Midazolam, a type IV sedative agent of moderate
post-mortem redistribution [4], which is affected by action, would has a synergistic effect when
cell death, decomposition, passive drug release from administered with propofol (used as an intravenous
400
Toxicological study of an exhumed body using alternative matrices for the detection of psychoactive drugs

anesthetic in critical medical care) [75] and in addition, 16. Hilberg T, Ripel Å, Slørdal L, Bjørneboe A, Mørland J. The extent
of post-mortem drug redistribution in a rat model. J Forensic Sci.
is incompatible with pentobarbital sodium, then, 1999; 44(5): 956-962.
simultaneous administration could have caused a 17. Hilberg T, Rogde S, Mørland J. Post-mortem drug redistribution-
serious adverse reaction through an inhibitory effect human cases related to results in experimental animals. J Forensic
on the cardiorespiratory centre [76], which it would be Sci. 1999; 44(1): 3-9.
18. Moriya F, Hashimoto Y. Redistribution of basic drugs into
possible to establish a causal link between the death of cardiac blood from surrounding tissues during early-stages post-
the subject and substances found - midazolam, propofol mortem. J Forensic Sci. 1999; 44(1): 10-16.
and pentobarbital - at the concentrations mentioned. 19. Dalpe-Scott M, Degouffe M, Garbutt D, Drost M. A comparison
of drug concentrations in post-mortem cardiac and peripheral
blood in 320 cases. Can Soc Forensic Sci J. 1995; 28(2): 113-121.
Conflict of interest 20. Gomez HF, McKinney P, Phillips S, Roberts DV, Brent J,
The authors declare that they have no conflict of Watson WA. Post-mortem acetaminophen pharmacokinetics:
an experimental study of site and time-dependent concentration
interest. changes. J Forensic Sci. 1995; 40(6): 980-982.
21. O’Sullivan JJ, McCarthy PT, Wren C. Differences in amiodarone,
digoxin, flecainide and sotalol concentrations between antemortem
serum and femoral post-mortem blood. Hum Exp Toxicol. 1995;
References 14(7): 605-608.
22. Shepherd MF, Lake KD, Kamps MA. Post-mortem changes and
1. Launiainen T, Ojanperä I. Drug concentrations in post‐mortem pharmacokinetics: review of the literature and case report. Ann
femoral blood compared with therapeutic concentrations in plasma. Pharmacother 1992; 26(4): 510-514.
Drug Test Anal. 2014; 6(4): 308-316. 23. Prouty RW, Anderson WH. The forensic science implications
2. Chamberlain J. The Analysis of Drugs in Biological Fluids, 2nd ed. of site and temporal influences on post-mortem blood-drug
CRC press. 1995; 1–33. concentrations. J Forensic Sci. 1990; 35(2): 243-270.
3. Caplan YH. Drug testing in alternate biological specimens. 24. Kugelberg FC, Jones AW. Interpreting results of ethanol analysis
Springer Science & Business Media. 2008. in post-mortem specimens: a review of the literature. Forensic Sci
4. Han E, Kim E, Hong H, Jeong S, Kim J, In S, Chung H, Lee Int. 2007; 165: 10–29.
S. Evaluation of post-mortem redistribution phenomena for 25. Schloegal H, Rost T, Schmidt W, Wurst FM, Weinmann W.
commonly encountered drugs. Forensic Sci Int. 2012; 219(1): 265- Distribution of ethyl glucuronide in rib bone marrow, other tissues
271. and body liquids as proof of alcohol consumption before death.
5. Mußhoff F, Daldrup T, Aderjan R, Meyer L. Anlagen zu den Forensic Sci Int. 2006; 156: 213–218.
Richtlinien zur Qualitätssicherung bei forensisch-toxikologischen 26. Iwasaki Y, Yashiki M, Namera A, Kojima T. On the influence
Untersuchungen [Annexes to the Guidelines for Quality Assurance of post-mortem alcohol diffusion from the stomach contents to the
in Forensic Toxicological Investigations]. Toxichem. Krimtech heart blood. Forensic Sci Int. 1998; 94: 111–118.
2002; 69: 32-34. 27. Sylverster PA, Wong NACS, Warren BF, Ranson DL.
6. Drummer OH. Post-mortem toxicology. Forensic Sci Int. 2007; Unacceptably high site variability in post-mortem blood alcohol
165(2): 199-203. analysis. J Clin Path. 1998; 51: 250–252.
7. Drummer OH, Gerastamoulos J. Post-mortem drug analysis: 28. Singer PP, Jones GR. Very unusual ethanol distribution in a
analytical and toxicological aspects. Ther Drug Monit. 2002; 24: fatality. J Anal Toxicol. 1997; 21: 506–508.
199–209. 29. Takayasu T, Ohshima T, Tanaka N, Maeda H, Kondo T,
8. Cippitelli M, Mirtella D, Ottaviani G, Tassoni G, Froldi R, Nishigami J, Ohtsuji M, Nagano T. Experimental studies on post-
Cingolani M. Toxicological analysis of opiates from alternative mortem diffusion of ethano-d6 using rats. Forensic Sci Int. 1995;
matrices collected from an exhumed body. J Forensic Sci. 2018; 76: 179–188.
63(2): 640-643. 30. Jones GR, Pounder DJ. Site dependence of drug concentrations
9. Grellner W, Glenewinkel F. Exhumations: synopsis of in post-mortem blood - a case study. J Anal Toxicol. 1987; 11: 186–
morphological and toxicological findings in relation to the post- 190.
mortem interval: survey on a 20-year period and review of the 31. Prouty RW, Anderson WH. A comparison of post-mortem
literature. Forensic Sci Int. 1997; 90(1-2): 139-159. heart blood and femoral blood ethyl alcohol concentrations. J Anal
10. Drummer OH, Kennedy B, Bugeja L, Ibrahim JE, Ozanne-Smith Toxicol. 1987; 11: 191–197.
J. Interpretation of post-mortem forensic toxicology results for 32. Noguchi TT, Nakamura GR, Griesemer EC. Drug analyses of
injury prevention research. Inj Prev. 2013; 19(4): 284-289. skeletonizing remains. J Forensic Sci. 1978; 23: 490–492.
11. Flanagan RJ, Connally G. Interpretation of analytical toxicology 33. Drummer OH. Forensic toxicology. Exs. 2010; 100: 579-603.
results in life and at post-mortem. Toxicol Rev. 2005; 24(1): 51-62. 34. Skopp G. Preanalytic aspects in post-mortem toxicology.
12. Forrest ARW. Obtaining samples at post mortem examination Forensic Sci Int. 2004; 142(2): 75-100.
for toxicological and biochemical analyses. J Clin Pathol. 1993; 35. Yawney J, Treacy S, Hindmarsh KW, Burczynski FJ. A general
48(4): 292-296. screening method for acidic, neutral, and basic drugs in whole
13. Vardakou I, Athanaselis S, Pistos C, Papadodima S, Spiliopoulou blood using the Oasis MCX® column. J Anal Toxicol. 2002; 26(6):
C, Moraitis K. The clavicle bone as an alternative matrix in forensic 325-332.
toxicological analysis. J Forensic Leg Med. 2014; 22: 7-9. 36. McIntyre IM, King CV, Boratto M, Drummer, OH. Post-mortem
14. Tominaga M, Michiue T, Ishikawa T, Kawamoto O, Oritani S, drug analyses in bone and bone marrow. Ther Drug Monit. 2000;
Ikeda K, Ogawa M, Maeda H. Post-mortem analyses of drugs in 22(1): 79-83.
pericardial fluid and bone marrow aspirate. J Anal Toxicol. 2013; 37. Marik PE. Propofol: therapeutic indications and side-effects.
37(7): 423-429. Curr Pharm Des. 2004; 10(29): 3639-3649.
15. Baselt RC. Disposition of toxic drugs and chemicals in man, 38. Molina DK, McCutcheon JR, Rulon JJ. Head injuries,
6th ed. Foster City, California: Chemical Toxicology Institute. pentobarbital, and the determination of death. Am J Forensic Med
Biomedical Publication. 2002. Pathol. 2009; 30(1): 75-77.
401
Pérez-Martínez C. et al.

39. McGrath KK, Jenkins AJ. Detection of drugs of forensic 58. Drummer OH, A fatality due to propofol poisoning. J Forensic
importance in post-mortem bone. Am J Forensic Med Pathol. 2009; Sci. 1992; 37(4): 1186-1189.
30(1): 40-44. 59. Cirimele V, Kintz P, Doray S, Ludes B. Determination of
40. Griffin III CE, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine chronic abuse of the anaesthetic agents midazolam and propofol as
pharmacology and central nervous system–mediated effects. demonstrated by hair analysis. Int J Legal Med. 2002; 116(1): 54-57.
Ochsner J. 2013; 13(2): 214-213. 60. Melo P, Costa P, Quintas MJ, Castro A, Tarelho S, Franco JM,
41. Kothary SP, Brown AC, Pandit UA, Samra SK, Pandit SK. Time Teixeira HM. Pentobarbital in the context of possible suicides:
course of antirecall effect of diazepam and lorazepam following oral Analysis of a Case. Forensic Sci Int. 2017; 274: 109-112.
administration. Anesthesiology. 1981; 55(6): 641-644. 61. Hangartner S, Steiner J, Dussy F, Moeckli R, Gerlach K,
42. Guillot E, De Mazincourt P, Durigon M, Alvarez JC. Morphine Briellmann T. A suicide involving intraperitoneal injection of
and 6-acetylmorphine concentrations in blood, brain, spinal cord, pentobarbital. Int J Legal Med. 2016; 5: 1217-1222.
bone narrow and bone after lethal acute or chronic diacetylmorphine 62. Cantrell FL, Nordt S, Mcintyre I, Schneir A. Death on the
administration to mice. Forensic Sci Int. 2007; 166: 139–144. doorstep of a border community–intentional self-poisoning with
43. Kirby RR, Colaw JM, Douglas MM. Death from propofol: veterinary pentobarbital. Clin Toxicol. 2010; 48(8): 849-850.
accident, suicide, or murder? Anesth Analg. 2009; 108(4): 1182- 63. Brandt-Casadevall C, Krompecher T, Giroud C, Mangin P. A
1184. case of suicide disguised as natural death. Sci Justice. 2003; 43(1):
44. Oertel R, Pietsch J, Arenz N, Zeitz SG, Goltz L, Kirch W. 41-43.
Distribution of metoprolol, tramadol, and midazolam in human 64. Romain N, Giroud C, Michaud K, Mangin P. Suicide by injection
autopsy material. J Chromatogr A. 2011; 1218(30): 4988-4994. of a veterinarian barbiturate euthanasia agent: report of a case and
45. Delabarde T, Keyser C, Tracqui A, Charabidze D, Ludes B. The toxicological analysis. Forensic Sci Int. 2003; 131(2): 103-107.
potential of forensic analysis on human bones found in riverine 65. Poklis A, Hameli AZ. Two unusual barbiturate deaths. Arch
environment. Forensic Sci Int. 2013; 228(1): e1-e5. Toxicol. 1975; 34(1): 77-80.
46. Yarema MC, Becker CE. Key concepts in post-mortem drug 66. Frison G, Favretto D, Tedeschi L, Ferrara SD. Detection of
redistribution. Clin Toxicol. 2005; 43(4): 235-241. thiopental and pentobarbital in head and pubic hair in a case of
47. Staeheli SN, Baumgartner MR, Gauthier S, Gascho D, Jarmer J, drug-facilitated sexual assault. Forensic Sci Int. 2003; 133(1): 171-
Kraemer T, Steuer AE. Time-dependent post-mortem redistribution 174.
of butyrfentanyl and its metabolites in blood and alternative 67. Dordevic S, Tomasevic G, Kilibarda V. Fatal Overdose with
matrices in a case of butyrfentanyl intoxication. Forensic Sci Int. Midazolam-Application of HPLC-PDA Method. Med Data Rev.
2016; 266: 170-177. 2010; 2(3): 251-255.
48. Kennedy MC. Post‐mortem drug concentrations. Intern Med J. 68. Nishiyama T, Hanaoka K. Accidental overdose of midazolam as
2010; 40(3): 183-187. intramuscular premedication. J Clin Anesth. 2002; 14(7): 543-555.
49. Chaudhary MT, Wattoo SA, Sarwar M, Tahir MA, Imran 69. Michalodimitrakis M, Christodoulou P, Tsatsakis AM,
M, Ashiq, MZ. Toxicological Analysis of Exhumed Specimen- Askoxilakis I, Stiakakis I, Mouzas I. Death related to midazolam
Challenge for the Toxicologists. Arab Journal of Forensic Sciences overdose during endoscopic retrograde cholangiopancreatography.
& Forensic Medicine. 2016; 1(3); 354-361. Am J Forensic Med Pathol. 1999; 20(1): 93-97.
50. Bardale R, Ambade V, Dixit P. Exhumation: A 10-year 70. Yashiki M, Miyazaki T, Iwasaki Y, Taniguchi T, Kozima T. A case
retrospective study. J Indian Acad Forensic Med. 2012; 34(2); 143- of suicide by an intravenous injection of pancuronium [in Japanese].
145. Nippon Hagaku Zasshi. 1992; 46(4): 282-285.
51. Karger B, Lorin de la Grandmaison G, Bajanowski T, Brinkmann 71. Ferslew KE, Hagardorn AN, McCormick WF. Post mortem
B. Analysis of 155 consecutive forensic exhumations with emphasis determination of the biological distribution of sufentanil and
on undetected homicides. Int J Legal Med. 2004; 118: 90–94. midazolam after an acute intoxication. J Forensic Sci. 1989; 34(1):
52. Klausz G, Róna K, Kristóf I, Törő K. Evaluation of a fatal propofol 249-257.
intoxication due to self administration. J Forensic Leg Med. 2009; 72. Kaferstein H, Stich G, Madea B. Chlorprothixene in bodies after
16(5): 287-289. exhumation. Forensic Sci Int. 2013; 229: 30–34.
53. Kranioti EF, Mavroforou A, Mylonakis P, Michalodimitrakis M. 73. Drummer OH. Post-mortem toxicology of drugs of abuse.
Lethal self administration of propofol (Diprivan): a case report and Forensic Sci Int. 2004; 142: 101–113.
review of the literature. Forensic Sci Int. 2007; 167(1): 56-58. 74. Moriya F, Hashimoto Y. Post-mortem stability of cocaine and
54. Roussin A, Mirepoix M, Lassabe G, Dumestre-Toulet V, Gardette cocaethylene in blood and tissues of humans and rabbits. J Forensic
V, Montastruc JL, Lapeyre-Mestre M. Death related to a recreational Sci. 1996; 41: 612–616.
abuse of propofol at therapeutic dose range [Correspondence]. Br J 75. Tominaga M, Michiue T, Ishikawa T, Kawamoto O, Oritani S,
Anaesth. 2006; 97(2): 268. Ikeda K, Maeda H. Post-mortem analyses of drugs in pericardial
55. Strehler M, Preuss J, Wollersen H, Madea B. Lethal mixed fluid and bone marrow aspirate. J Anal Toxicol. 2013; 37(7): 423-
intoxication with propofol in a medical layman. Arch Kriminol. 429.
2006; 217(5-6): 153-160. 76. Agencia española de medicamentos y productos sanitarios
56. Iwersen-Bergmann S, Rösner P, Kühnau HC, Junge M, Schmoldt (AEMPS). Ficha Técnica Midazolam. https://www.aemps.gob.es/
A. Death after excessive propofol abuse. Int J Legal Med. 2001; cima/pdfs/es/ft/64092/P_64092.pdf; 2009 Accessed 29 November
114(4-5): 248-251. 2017.
57. Chao TC, Lo DST, Chui PPS, Koh TH. The first fatal 2, 6-di-
isopropylphenol (propofol) poisoning in Singapore: a case report.
Forensic Sci Int. 1994; 66(1): 1-7.

402

You might also like